Atlas Trials

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal

Clinical trial NCT02634528 · COMPLETED

Trial details

NCT number
NCT02634528
Sponsor
Julphar Gulf Pharmaceutical Industries
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2016-11-16
Primary completion
2017-01-20
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.